Nanodigmbio and Gminix Signed a Strategic Partnership Agreement

On November 20, 2019, Shanghai Nanodigmbio Biotechnology Co., Ltd. (hereinafter referred to as "Nanodigmbio") and Shanghai Gminix Information Technology Co., Ltd. (hereinafter referred to as "Gminix") successfully signed a strategic partnership agreement in Shanghai, China, announcing the establishment of a strategic partnership.

This strategic partnership aims to give full play to their respective advantages and work together to carry out comprehensive cooperation in next generation sequencing (NGS), such as genetic testing and precision medicine. The cooperation will make full use of the comprehensive advantages of Nanodigmbio's targeted sequencing products and Gminix‘s bioinformatics platform to jointly create the exceptional NGS products.

At the signing ceremony of the strategic cooperation agreement, the two parties discussed how to achieve win-win cooperation to provide high-quality service and products to the customers.